NetworkNewsBreaks

WednesdayJul 17, 2024 1:06 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at the 73rd Emerging Growth Conference

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company is presenting at the 73rd Emerging Growth Conference, scheduled for July 17-18, 2024. Clene’s presentation is slated to begin at 4:45 p.m. EDT on July 18, with Rob Etherington, Clene’s President and CEO, and Morgan Brown, Clene’s CFO, giving the presentation. To view the full press release, visit https://nnw.fm/1W5Ka About Clene Inc. Clene (along with…

Continue Reading

WednesdayJul 17, 2024 12:08 pm

NetworkNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) 2024 Mullen ONE EV Cargo Van Qualifies for up to $3,500 Rebate under Massachusetts’ MOR-EV Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing that the Massachusetts Executive Office of Energy and Environmental Affairs’ Department of Energy Resources (“DOER”) has approved the company’s 2024 Mullen ONE, an all-electric Class 1 cargo van, for up to $3,500 cash voucher under its MOR-EV program. Managed by DOER and administered statewide by the Center for Sustainable Energy (“CSE”), MOR-EV is committed to making electric vehicles more affordable for Massachusetts residents, businesses and non-profit organizations to help achieve clean transportation goals and reduce greenhouse gas emissions and provide more equitable access to EVs. The announcement noted…

Continue Reading

WednesdayJul 17, 2024 11:19 am

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Inks LOI Outlining Plans to Acquire Leading Wholesaler, Distributor of Food-Services Custom Takeout Packaging

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, has signed a letter of intent (“LOI”) to acquire SWC Group Inc., doing business as Carryoutsupplies.com (“CarryOut”), through Nightfood’s wholly owned subsidiary, Future Hospitality Ventures Holdings Inc. As outlined in the LOI, the acquisition will be an all-stock transaction. A leading wholesaler and distributor of custom takeout packaging for the foodservice industry, CarryOut specializes in traditional and ecofriendly custom-printed packaging solutions for food-service businesses. Its products include to-go hot food boxes, snacks bowls, sushi trays, soup cups, ice cream cups and lids, coffee cups and lids, utensils, and more. According to…

Continue Reading

WednesdayJul 17, 2024 10:24 am

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Enters Strategic Partnership to Support Rollout of Telemedicine Services across the US

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, is announcing a strategic partnership with HC Smart, Inc., a national telemedicine provider. The partnership, set to go live within the next four weeks, is expected to extend HealthLynked’s telemedicine services across the U.S. as well as significantly enhance the company’s offerings and accessibility. The announcement stated that the collaboration will integrate HC Smart’s advanced telemedicine capabilities into HealthLynked’s existing platform, providing nationwide coverage to all HealthLynked members. This initiative will offer HealthLynked Network members access to high-quality healthcare from the comfort of their homes by enabling reduced-cost telemedicine consultations as part…

Continue Reading

WednesdayJul 17, 2024 9:36 am

NetworkNewsBreaks – Blockchain Life 2024 Announces Initial Lineup of Speakers, Anticipates Attendance of 10,000+

Blockchain Life, one of the world’s leading event producers in web3, cryptocurrencies and mining sphere, recently unveiled its speaker lineup for the next event taking place in Dubai on October 22-23, 2024. Speakers include Paolo Ardoino, CEO of Tether; Xinxi Wang, Co-Founder of Litecoin Foundation; Robby Yung, CEO of Animoca Brands; Sasha Plotvinov, Founder of Notcoin; Eowyn Chen, CEO of Trust Wallet; and Alena Shmalko of TON Foundation. “We are thrilled to announce this exceptional lineup of speakers for Blockchain Life 2024,” said Sergei Khitrov, Founder of the event. “These are just the first speakers and most are still kept secret.…

Continue Reading

TuesdayJul 16, 2024 3:40 pm

NetworkNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Reports on Plans to Explore Eastern Extent at Duquesne West Gold Project

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH), an advanced-stage, gold-exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project, announced that it is exploring the eastern portion of the project. According to the announcement, that exploration includes a “conceptual open pit model toward the Nip Zone, focusing on untested potentially high-grade gold targets after completing 30% (2,500 meters) of the ongoing 8,000-meter drill program at the Duquesne West Gold Project.” The company reported robust thickness of high-grade gold intercepts at the Nip Zone, making the area a top priority for exploration. Noting that…

Continue Reading

TuesdayJul 16, 2024 3:36 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names New Medical Advisory Board Member

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, has appointed a new member to its medical advisory board. According to the announcement, Mark Gilbert, MD, will be joining the board, bringing board membership to eight. A scientist emeritus at the National Institutes of Health (“NIH”), Gilbert served as chief of the neurooncology branch at NIH for a decade. During that time, Gilbert facilitated a team of laboratory and clinical investigators involved in groundbreaking research that advanced science in the brain tumor field. In addition to his experience at NIH, Gilbert practiced under world-renowned…

Continue Reading

TuesdayJul 16, 2024 3:15 pm

NetworkNewsBreaks – U.S. Government and Social Media Giants Tackle Synthetic Drug Distribution

The United States government’s recent memorandum with major social media companies, including Meta Platforms (NASDAQ: META), X and Snap (NYSE: SNAP), marks a significant step in the fight against the distribution of synthetic drugs online. Snap, known for its Snapchat application, is at the forefront of this initiative, showcasing its commitment to corporate responsibility. This collaboration aims to leverage the extensive reach and influence of these platforms to address a critical public health concern. Snap, alongside its peers Meta and X, plays a pivotal role in the digital ecosystem, with millions of users engaging on their platforms daily. The agreement to curb…

Continue Reading

TuesdayJul 16, 2024 2:57 pm

NetworkNewsBreaks – Bluejay Diagnostics Inc. (NASDAQ: BJDX) Closes $8.75M Underwritten Public Offering

Bluejay (NASDAQ: BJDX), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, recently announced the closing of a firm commitment underwritten public offering. Expected gross proceeds to the company were approximately $8.75 million. The base offering consisted of 5,368,098 common units or prefunded units, each unit consisting of one share of the company’s common stock or one pre-funded warrant to purchase one share of common Stock, two Class C warrants each to purchase one share of common stock and one Class D warrant to purchase such number of shares of…

Continue Reading

TuesdayJul 16, 2024 2:39 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in tomorrow’s Virtual Investor Closing Bell Series. According to the announcement, CNS Pharmaceuticals CEO John Climaco will be presenting via a live video webcast at 4 p.m. on July 17. The presentation will include a corporate overview and will also feature a live question-and-answer period. A replay of the webcast will be available following the live presentation and will be accessible for 90 days. To view the presentation, visit https://nnw.fm/7TeMd To…

Continue Reading